Abstract
Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease. It is characterized by a progressive loss of dopamine in the substantia nigra and striatum. However, over 70% of dopaminergic neuronal death occurs before the first symptoms appear, which makes either early diagnosis or effective treatments extremely difficult. Only symptomatic therapies have been used, including levodopa (l-dopa), to restore dopamine content; however, the use of l-dopa leads to some long-term pro-oxidant damage. In addition to a few specific mutations, oxidative stress and generation of free radicals from both mitochondrial impairment and dopamine metabolism are considered to play critical roles in PD etiology. Thus, the use of antioxidants as an important co-treatment with traditional therapies for PD has been suggested. Melatonin, or N-acetyl-5-methoxy-tryptamine, an indole mainly produced in the pineal gland, has been shown to have potent endogenous antioxidant actions. Because neurodegenerative disorders are mainly caused by oxidative damage, melatonin has been tested successfully in both in vivo and in vitro models of PD. The present review provides an up-to-date account of the findings and mechanisms involved in neuroprotection of melatonin in PD.
Similar content being viewed by others
References
de Rijk, M. C., Launer, L. J., Berger, K., et al. (2000). Neurology 54, S21-S23.
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., and Goedert, M. (1998). Proc. Natl. Acad. Sci. USA 95, 6469–6473.
Huang, Y., Cheung, L., Rowe, D., and Halliday, G. (2004). Brain Res. Brain Res. Rev. 46, 44–70.
Vila, M. and Przedborski, S. (2004). Nat. Med. 10(Suppl.), S58-S62.
Halliwell, B. and Gutteridge, J. M. C. (eds.) (1999). Free radicals in biology and medicine. Oxford University Press: Oxford, UK.
Halliwell, B. and Gutteridge, J. M. (1984). Lancet 1, 1396–1397.
Halliwell, B. and Whiteman, M. (2004). Br. J. Pharmacol. 142, 231–255.
Dexter, D. T., Sian, J., Jenner, P., and Marsden, C. D. (1993). Adv. Neurol. 60, 273–281.
Youdim, M. B., Stephenson, G., and Ben Shachar, D. (2004). Ann. NY Acad. Sci. 1012, 306–325.
Sian, J., Dexter, D. T., Lees, A. J., et al. (1994). Ann. Neurol. 36, 348–355.
Dexter, D. T., Carter, C. J., Wells, F. R., et al. (1989). J. Neurochem. 52, 381–389.
Sanchez-Ramos, J., Overvik, E., and Ames, A. B. (1994). Neurodegeneration 3, 197–204.
Schapira, A. H. (1998). Biochim. Biophys. Acta 1366, 225–233.
Beal, M. F. (2003). Ann. NY Acad. Sci. 991, 120–131.
Beal, M. F. (1998). Ann. Neurol. 44, S110-S114.
Graham, D. G. (1978). Mol. Pharmacol. 14, 633–643.
Spina, M. B. and Cohen, G. (1988). J. Pharmacol. Exp. Ther. 247, 502–507.
Zecca, L., Youdim, M. B., Riederer, P., Connor, J. R., and Crichton, R. R. (2004). Nat. Rev. Neurosci. 5, 863–873.
Tieu, K., Ischiropoulos, H., and Przedborski, S. (2003). IUBMB Life 55, 329–335.
Carreras, M. C., Franco, M. C., Peralta, J. G., and Poderoso, J. J. (2004). Mol. Aspects Med. 25, 125–139.
Schulz, J. B., Matthews, R. T., Muqit, M. M., Browne, S. E., and Beal, M. F. (1995). J. Neurochem. 64, 936–939.
Przedborski, S., Jackson-Lewis, V., Yokoyama, R., Shibata, T., Dawson, V. L., and Dawson, T. M. (1996). Proc. Natl. Acad. Sci. USA 93, 4565–4571.
Wu, D. C., Jackson-Lewis, V., Vila, M., et al. (2002). J. Neurosci. 22, 1763–1771.
Olanow, C. W., Agid, Y., Mizuno, Y., et al. (2004). Mov. Disord. 19, 997–1005.
Dauer, W. and Przedborski, S. (2003). Neuron 39, 889–909.
Meissner, W., Hill, M. P., Tison, F., Gross, C. E., and Bezard, E. (2004). Trends Pharmacol. Sci. 25, 249–253.
Stocchi, F. and Olanow, C. W. (2003). Ann. Neurol. 53(Suppl. 3), S87-S97.
Langston, J. W., Ballard, P., Tetrud, J. W., and Irwin, I. (1983). Science 219, 979–980.
Liu, Y., Roghani, A., and Edwards, R. H. (1992). Proc. Natl. Acad. Sci. USA 89, 9074–9078.
Nicklas, W. J., Vyas, I., and Heikkila, R. E. (1985). Life Sci. 36, 2503–2508.
Ungerstedt, U., Ljungberg, T., and Steg, G. (1974). Adv. Neurol. 5, 421–426.
Cohen, G. and Kesler, N. (1999). J. Neurochem. 73, 2310–2315.
Day, B. J., Patel, M., Calavetta, L., Chang, L. Y., and Stamler, J. S. (1999). Proc. Natl. Acad. Sci. USA 96, 12760–12765.
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., and Greenamyre, J. T. (2000). Nat. Neurosci. 3, 1301–1306.
Sherer, T. B., Betarbet, R., Testa, C. M., et al. (2003). J. Neurosci. 23, 10756–10764.
Good, P. F., Hsu, A., Werner, P., Perl, D. P., and Olanow, C. W. (1998). J. Neuropathol. Exp. Neurol. 57, 338–342.
Dennis, J. and Bennett, J. P. Jr. (2003). J. Neurosci. Res. 72, 89–97.
Schapira, A. H., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., and Marsden, C. D. (1990). J. Neurochem. 54, 823–827.
Gu, M., Cooper, J. M., Taanman, J. W., and Schapira, A. H. (1998). Ann. Neurol. 44, 177–186.
Swerdlow, R. H., Parks, J. K., Miller, S. W., et al. (1996). Ann. Neurol. 40, 663–671.
Sheehan, J. P., Swerdlow, R. H., Parker, W. D., Miller, S. W., Davis, R. E., and Tuttle, J. B. (1997). J. Neurochem. 68, 1221–1233.
Vila, M. and Przedborski, S. (2003). Nat. Rev. Neurosci. 4, 365–375.
Hartmann, A., Hunot, S., Michel, P. P., et al. (2000). Proc. Natl. Acad. Sci. USA 97, 2875–2880.
Yang, L., Matthews, R. T., Schulz, J. B., et al. (1998). J. Neurosci. 18, 8145–8152.
Tatton, N. A. and Kish, S. J. (1997). Neuroscience 77, 1037–1048.
Kreutzberg, G. W. (1996). Trends Neurosci. 19, 312–318.
Liu, B., Gao, H. M., and Hong, J. S. (2003). Environ. Health Perspect. 111, 1065–1073.
Lindsay, R. M., Wiegand, S. J., Altar, C. A., and DiStefano, P. S. (1994). Trends Neurosci. 17, 182–190.
Qin, L., Liu, Y., Cooper, C., Liu, B., Wilson, B., and Hong, J. S. (2002). J. Neurochem. 83, 973–983.
Kim, W. G., Mohney, R. P., Wilson, B., Jeohn, G. H., Liu, B., and Hong, J. S. (2000). J. Neurosci. 20, 6309–6316.
Hunt, S., Boissiere, F., Faucheux, B., et al. (1996). Neuroscience 72, 355–363.
Hunot, S., Dugas, N., Faucheux, B., et al. (1999). J. Neurosci. 19, 3440–3447.
Teismann, P., Vila, M., Choi, D. K., et al. (2003). Ann. NY Acad. Sci. 991, 272–277.
Teismann, P., Tieu, K., Choi, D. K., et al. (2003). Proc. Natl. Acad. Sci. USA 100, 5473–5478.
Gao, H. M., Jiang, J., Wilson, B., Zhang, W., Hong, J. S., and Liu, B. (2002). J. Neurochem. 81, 1285–1297.
Reiter, R. J. (1991). Mol. Cell Endocrinol. 79, C153-C158.
Gern, W. A. and Ralph, C. L. (1979). Science 204, 183–184.
Menendez-Pelaez, A., Reiter, R. J., Howes, K. A., et al. (1988). Endocr. Res. 14, 121–130.
Tan, D. X., Manchester, L. C., Reiter, R. J., et al. (1999). Biochim. Biophys. Acta 1472, 206–214.
Hardeland, R. and Poeggeler, B. (2003). J. Pineal Res. 34, 233–241.
Reiter, R. J. (1991). Endocr. Rev. 12, 151–180.
Blask, D. E., Sauer, L. A., Dauchy, R. T., Holowachuk, E. W., and Ruhoff, M. S. (1999). Adv. Exp. Med. Biol. 460, 337–343.
Fraschini, F. and Reiter, R. J. (eds.) (1991). Role of melatonin and pineal peptides in neuroimmunomodulation. Plenum Press: New York.
Guerrero, J. M. and Reiter, R. J. (2002). Curr. Top. Med. Chem. 2, 167–179.
Tan, D. X., Chen, L. D., Poeggeler, B., Manchester, L. C., and Reiter, R. J. (1993). Endocr. J. 1, 57–60.
Tan, D. X., Manchester, L. C., Reiter, R. J., et al. (1998). Biochem. Biophys. Res. Commun. 253, 614–620.
Tan, D. X., Manchester, L. C., Burkhardt, S., et al. (2001). FASEB J. 15, 2294–2296.
Barlow-Walden, L. R., Reiter, R. J., Abe, M., et al. (1995). Neurochem. Int. 26, 497–502.
Mayo, J. C., Sainz, R. M., Antoli, I., Herrera, F., Martin, V., and Rodriguez, C. (2002). Cell Mol. Life Sci. 59, 1706–1713.
Antolin, I., Rodriguez, C., Sainz, R. M., et al. (1996). FASEB J. 10, 882–890.
Sofic, E., Rimpapa, Z., Kundurovic, Z., et al. (2005). J. Neural Transm. 112, 349–358.
Tan, D. X., Reiter, R. J., Manchester, L. C., et al. (2002). Curr. Top. Med. Chem. 2, 181–197.
Reiter, R. J., Tan, D. X., and Pappolla, M. A. (2004). Ann. NY Acad. Sci. 1035, 179–196.
Sewerynek, E., Melchiorri, D., Ortiz, G. G., Poeggeler, B., and Reiter, R. J. (1995). J. Pineal Res. 19, 51–56.
Mohanan, P. V. and Yamamoto, H. A. (2002). Toxicol. Lett. 129, 99–105.
Lopez-Burillo, S., Tan, D. X., Mayo, J. C., Sainz, R. M., Manchester, L. C., and Reiter, R. J. (2003). J. Pineal Res. 34, 269–277.
Mayo, J. C., Tan, D. X., Sainz, R. M., Natarajan, M., Lopez-Burillo, S., and Reiter, R. J. (2003). Biochim. Biophys. Acta 1620, 139–150.
Stefulj, J., Hortner, M., Ghosh, M., et al. (2001). J. Pineal Res. 30, 243–247.
Tan, D. X., Manchester, L. C., Hardeland, R., et al. (2003). J. Pineal Res. 34, 75–78.
Borlongan, C. V., Yamamoto, M., Takei, N., et al. (2000). FASEB J. 14, 1307–1317.
Cheung, R. T. (2003). J. Pineal Res. 34, 153–160.
Reiter, R. J., Tan, D. X., Leon, J., Kilic, U., and Kilic, E. (2005). Exp. Biol. Med. (Maywood.) 230, 104–117.
Antolin, I., Mayo, J. C., Sainz, R. M., et al. (2002). Brain Res. 943, 163–173.
Pappolla, M. A., Simovich, M. J., Bryant-Thomas, T., et al. (2002). J. Pineal Res. 32, 135–142.
Reiter, R. J., Cabrera, J., Sainz, R. M., Mayo, J. C., Manchester, L. C., and Tan, D. X. (1999). Ann. NY Acad. Sci. 890, 471–485.
Sandyk, R. (1990). Int. J. Neurosci. 50, 37–53.
Miller, J. W., Selhub, J., and Joseph, J. A. (1996). Free Radic. Biol. Med. 21, 241–249.
Khaldy, H., Escames, G., Leon, J., Vives, F., Luna, J. D., and Acuna-Castroviejo, D. (2000). J. Pineal Res. 29, 100–107.
Acuna-Castroviejo, D., Coto-Montes, A., Gaia, M. M., Ortiz, G. G., and Reiter, R. J. (1997). Life Sci. 60, L23-L29.
Jin, B. K., Shin, D. Y., Jeong, M. Y., et al. (1998). Neurosci. Lett. 245, 61–64.
Kim, Y. S., Joo, W. S., Jin, B. K., Cho, Y. H., Baik, H. H., and Park, C. W. (1998). Neuroreport 9, 2387–2390.
Joo, W. S., Jin, B. K., Park, C. W., Maeng, S. H., and Kim, Y. S. (1998). Neuroreport 9, 4123–4126.
Ortiz, G. G., Crespo-Lopez, M. E., Moran-Moguel, C., Garcia, J. J., Reiter, R. J., and Acuna-Castroviejo, D. (2001). Neuroendocrinol. Lett. 22, 101–108.
Dabbeni-Sala, F., Di Santo, S., Franceschini, D., Skaper, S. D., and Giusti, P. (2001). FASEB J. 15, 164–170.
Leon, J., Acuna-Castroviejo, D., Escames, G., Tan, D. X., and Reiter, R. J. (2005). J. Pineal Res. 38, 1–9.
Khaldy, H., Escames, G., Leon, J., Bikjdaouene, L., and Acuna-Castroviejo, D. (2003). Neurobiol. Aging 24, 491–500.
Chen, S. T., Chuang, J. I., Hong, M. H., and Li, E. I. (2002). J. Pineal Res. 32, 262–269.
Thomas, B. and Mohanakumar, K. P. (2004). J. Pineal Res. 36, 25–32.
Coulom, H. and Birman, S. (2004). J. Neurosci. 24, 10993–10998.
Iacovitti, L., Stull, N. D., and Johnston, K. (1997). Brain Res. 768, 317–326.
Iacovitti, L., Stull, N. D., and Mishizen, A. (1999). Brain Res. 816, 276–285.
Walkinshaw, G. and Waters, C. M. (1994). Neuroscience 63, 975–987.
Andersen, J. K. (2001). Bioessays 23, 640–646.
Mayo, J. C., Sainz, R. M., Uria, H., Antolin, I., Esteban, M. M., and Rodriguez, C. (1998). J. Pineal Res. 24, 179–192.
Mayo, J. C., Sainz, R. M., Antolin, I., and Rodriguez, C. (1999). Brain Res. 818, 221–227.
Pappolla, M. A., Sos, M., Omar, R. A., et al. (1997). J. Neurosci. 17, 1683–1690.
Feng, Z. and Zhang, J. T. (2004). J. Pineal Res. 37, 257–266.
Cazevieille, C., Safa, R., and Osborne, N. N. (1997). Brain Res. 768, 120–124.
Herrera, F., Sainz, R. M., Mayo, J. C., Martin, V., Antolin, I., and Rodriguez, C. (2001). J. Pineal Res. 31, 356–362.
Jou, M. J., Peng, T. I., Reiter, R. J., Jou, S. B., Wu, H. Y., and Wen, S. T. (2004). J. Pineal Res. 37, 55–70.
Imam, S. Z., el Yazal, J., Newport, G. D., et al. (2001). Ann. NY Acad. Sci. 939, 366–380.
Lezoualc’h, F., Sparapani, M., and Behl, C. (1998). J. Pineal Res. 24, 168–178.
Chetsawang, B., Govitrapong, P., and Ebadi, M. (2004). Neurosci. Lett. 371, 205–208.
Martin, V., Sainz, R. M., Antolin, I., Mayo, J. C., Herrera, F., and Rodriguez, C. (2002). J. Pineal Res. 33, 204–212.
Mayo, J. C., Tan, D. X., Sainz, R. M., Lopez-Burillo, S., and Reiter, R. J. (2003). Free Radic. Res. 37, 543–553.
Armstrong, K. J. and Niles, L. P. (2002). Neuroreport 13, 473–475.
Chung, S. Y. and Han, S. H. (2003). J. Pineal Res. 34, 95–102.
Martin, M., Macias, M., Leon, J., Escames, G., Khaldy, H., and Acuna-Castroviejo, D. (2002). Int. J. Biochem. Cell Biol. 34, 348–357.
Martin, M., Macias, M., Escames, G., Leon, J., and Acuna-Castroviejo, D. (2000). FASEB J. 14, 1677–1679.
Acuna, C. D., Escames, G., Carazo, A., Leon, J., Khaldy, H., and Reiter, R. J. (2002). Curr. Top. Med. Chem. 2, 133–151.
Boeve, B. F., Silber, M. H., and Ferman, T. J. (2003). Sleep Med. 4, 281–284.
Boeve, B. F., Silber, M. H., and Ferman, T. J. (2004). J. Geriatr. Psychiatry Neurol. 17, 146–157.
Bruguerolle, B. and Simon, N. (2002). Clin. Neuropharmacol. 25, 194–201.
Sandyk, R. (1990). Int. J. Neurosci. 51, 73–77.
Bordet, R., Devos, D., Brique, S., et al. (2003). Clin. Neuropharmacol. 26, 65–72.
Stull, N. D., Polan, D. P., and Iacovitti, L. (2002). Brain Res. 931, 181–185.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mayo, J.C., Sainz, R.M., Tan, DX. et al. Melatonin and parkinson’s disease. Endocr 27, 169–178 (2005). https://doi.org/10.1385/ENDO:27:2:169
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:27:2:169